Joel Marcus, the real estate tycoon credited with helping to turn Cambridge, Mass., into one of the world’s biggest biotech hubs, has lost a key battle in a legal war against his son.

A federal judge in California on Thursday dismissed a suit by Marcus’s firm, Alexandria Real Estate Equities, which had accused Steven Marcus of trademark infringement and unfair competition.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Both father and son have enough material wealth for all of their remaining days. What they don’t have is what every Dad wants, his child’s respect, and what every child wants, to feel protected by his father (no matter one’s age.) A digital pox on both their houses – grow up while you still have each other.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy